logo
Questions? +1 (202) 335-3939 Login
Set Up FREE Account Submit Release
Trusted News Since 1995
A service for global professionals · Friday, May 1, 2026 · 909,617,223 Articles · 3+ Million Readers
Home  •••  Newswires by Industry  •  Countries  •  U.S. States  •  World Media Directory
Companies News  •••  Topics  •  Countries  •  U.S. States

Novartis Profits News Monitoring

  • Published on Apr 29, 2026

    Novartis’ Q1 sales miss hints at industry’s utilisation of M&A remedies

    A weak Q1 for Novartis that was heavily impacted by generics erosion showcases that the billions of dollars being spent by the pharma industry to shore up revenue streams amid a looming patent cliff will likely be well placed. The Swiss drugmaker reported …

    Source: Pharmaceutical Technology - Pending
  • Published on Apr 29, 2026

    Novartis, PTC push Huntington’s drug into Phase 3, mum on accelerated approval

    Following encouraging mid-stage data, Novartis and PTC Therapeutics have decided to advance their Huntington’s disease candidate into late-stage development—a move that analysts say demonstrates the partners’ confidence in the program but also their …

    Source: BioSpace - Pending
  • Published on Apr 28, 2026

    Novartis shares fall as Entresto sales weaken

    Novartis has started to show the effects of its patent cliff more strongly, with sales and profits falling in the first quarter of this year on generic competition. Net sales fell 5%, or 1% at constant currencies, to $13.1 billion due to generic erosion of …

    Source: pharmaphorum - Neutral
  • Published on Apr 28, 2026

    Novartis’ sales dip as generics pressure intensifies, radioequivalents loom

    Looming competition for Novartis’ radioligand portfolio will have “minimal effect” on market performance in the coming years, CEO Vas Narasimhan contended, as the Swiss pharma faces pressures from incoming generic versions of Lutathera. Narasimhan was …

    Source: BioSpace - Pending
  • Published on Apr 28, 2026

    Novartis misses Q1 profit, sales estimates as generics hurt blockbuster Entresto sales

    Audio By Carbonatix By Bhanvi Satija and Marleen Kaesebier LONDON, April 28 (Reuters) – Novartis posted first-quarter core operating profit and revenues below market expectations on Tuesday, hit by a slump in sales of its blockbuster heart drug Entresto …

    Source: SRN News - Center-right
  • Published on Apr 28, 2026

    Novartis misses Q1 profit estimates on steep generic erosion

    Group operating income is down by 12% at US$4.9 billion, below analyst expectations of US$5.1 billionPublished Tue, Apr 28, 2026 · 04:52 PM [BASEL] Swiss drugmaker Novartis reported first-quarter core operating profit below market expectations on Tuesday ( …

    Source: The Business Times Singapore - Neutral
  • Published on Apr 28, 2026

    Novartis feels heat from copycat drugs

    Novartis' copycat products put pressure on business at the start of the year Keystone-SDA Novartis has felt the dampening effect of generic drugs at the start of the year. Nevertheless, management confirmed its previous outlook for the further course …

    Source: Swissinfo - Public Broadcaster
  • Published on Apr 28, 2026

    Novartis misses quarterly sales, profit estimates as Entresto generics hit growth

    Novartis Q1 Sales Miss Estimates as Entresto Generics Hit Growth Prospects Novartis Faces Challenges from Entresto Generics and Patent Expiries First-Quarter Financial Performance April 28 (Reuters) - Swiss drugmaker Novartis reported first-quarter core …

    Source: Global Banking & Finance Review - Neutral
  • Published on Apr 28, 2026

    Novartis Q1 profit down on US generic erosion

    April 28 (Reuters) - Swiss drugmaker ‌Novartis reported ‌first-quarter core operating ​profit below market expectations on Tuesday, as ‌generic ⁠competition for its top-selling ⁠heart drug Entresto weighed ​on ​sales. Quarterly ​group operating ‌income, …

    Source: Yahoo Finance - Center-left
  • Published on Apr 27, 2026

    Novartis secures pair of regulatory wins for skin disease and malaria treatments

    Novartis has netted a pair of regulatory wins, winning European approval for an oral therapy in chronic spontaneous urticaria (CSU) and, separately, receiving World Health Organization (WHO) prequalification for its antimalarial medication. The European …

    Source: Pharmaceutical Business Review - Pending
  • Published on Apr 26, 2026

    Novartis Antimalarial Clears Key WHO Review to Get the Combo Drug to Babies

    The first antimalarial developed specifically for babies is a step closer to reaching parts of the world where malaria is endemic. The World Health Organization has completed its review of Coartem Baby, clearing the way for entities that provide medicines …

    Source: MedCity News - Neutral
  • Published on Apr 26, 2026

    Novartis malaria treatment Coartem® Baby receives WHO prequalification

    Novartis malaria treatment Coartem® Baby receives WHO prequalification April 26, 2026 | Sunday | News Coartem® (artemether-lumefantrine) Baby is the first and only malaria treatment for newborns and young infants Novartis has announced that the World …

    Source: Biospectrum Asia - Neutral
  • Published on Apr 24, 2026

    Novartis Secures WHO Nod For Infant Malaria Therapy Coartem Baby

    Novartis (NVS) has announced that the World Health Organization (WHO) has prequalified Coartem Baby, the first and only malaria treatment developed specifically for newborns and young infants weighing between 2 and 5 kilograms. This milestone paves the way …

    Source: RTTNews - Neutral
  • Published on Apr 30, 2026

    New WHO malaria drug for babies will improve dosing, not cut mortality: Expert

    The World Health Organisation’s first malaria drug formulated for newborns will help prevent overdose but is unlikely to reduce malaria deaths in Nigeria, a public health physician, Ifeoluwa Odedina, says. Mr Odedina, from the University College Hospital, …

    Source: Peoples Gazette - Neutral
  • Published on Apr 29, 2026

    Biogen beats estimates as Alzheimer’s drug gains momentum

    Biogen Inc.’s first-quarter sales and profit beat expectations, a sign that the company’s Alzheimer’s drug and cost cuts are helping offset pressure on its multiple sclerosis franchise. Revenue rose 2 percent to $2.5 billion and adjusted earnings grew 18 …

    Source: The Boston Globe - Massachusetts - Center-left
  • Published on Apr 29, 2026

    Four to receive UB President’s Medal

    UB Provost A. Scott Weber, faculty members Allison Brashear and Andrew Whittaker, and Gregory M. Bauer, chairman of the UB Foundation Board of Trustees, are this year’s recipients of the UB President’s Medal in recognition of extraordinary service to the …

    Source: UB Now - Neutral
  • Published on Apr 28, 2026

    S&P 500 Valuation Looks Exposed as AI Spending Doubts Hit Tech

    The melt-up that carried the S&P 500 (SPX) and the Nasdaq Composite (COMP) to fresh all-time closing highs on Monday hit a wall on Tuesday, with risk appetite crumbling under the weight of two distinct shocks: a Wall Street Journal scoop revealing that …

    Source: Investing - Neutral
  • Published on Apr 29, 2026

    Europe set for modestly firmer open after a slew of earnings, USD and Brent firm a touch on WSJ report - Newsquawk EU ...

    Trump has told officials to prepare for an extended blockade of Iran, WSJ; Trump said they are doing very well in the Middle East. APAC equity performance incrementally improved across the session, with outperformance in the Hang Seng & Shanghai …

    Source: Zero Hedge - Right-wing
  • Published on Apr 29, 2026

    ISM® Honors Farryn Melton with 2026 J. Shipman Gold Medal Award

    Former Fortune 100 chief procurement officer recognized for leadership that strengthened the supply chain profession and the people who power it DENVER, April 28, 2026 /PRNewswire/ -- Institute for Supply Management® (ISM®) named Farryn C. Melton …

    Source: WFMZ - Pennsylvania - Neutral

03 days 17:16:46

Featured Releases

Got News to Share? · Submit · See All
Got news to share? Submit it now.
search news using your own keywords. There are 909,617,223 articles in our news database.

Online News Monitoring Made Simple

Established in 1995, EIN Newsdesk helps millions of users track breaking news across thousands of trusted websites. Users may set up custom email newsletters and RSS feeds or search among thousands of preset news sections. As a member, you may also submit your own news using the EIN Presswire distribution service. Membership is free and we do not sell or lease any information about you. Press release distribution, dedicated APIs, and custom services generate the revenue that allow us to offer you free basic access.

News by Country & by Industry

Worldwide News Coverage

Track news across more than 5,000 sources by country or industry or search our real-time news index.

Companies A-Z >
Online News Publications >
World News Report >

News Alerts & News Feeds

Custom News Monitoring

News page results can be outputted as RSS or received daily by email. You may also use our NewsPlugin for WordPress.

Create Email Newsletter >
Create RSS Feed >
NewsPlugin for WordPress >

Submit News

PR Distribution Service

Our EIN Presswire's distribution footprint reaches millions. You can upload news which is re-published through EIN Newsdesk, fed into Twitter and Facebook, and onto partner sites, Google News, Bing News, etc.

EIN Presswire >
Events >

World Media Directory

News Media Guide

This is a listing of the world’s TV stations, radio stations, newspapers, and blogs. Last update: 04/13/2026

World Media Directory >

Companies Press Releases

Got News to Share? · Submit · See All
Got news to share? Submit it now.

Companies Events

See All

No event was found.

Become a Member - Join Today!
Join thousands of professionals. Stay current. Stay competitive.
  • Track news from thousands of sources
  • Submit news sources for inclusion in our news tracking algorithm
  • Build your own customized email newsletters
  • Use of our RSS Feeds
  • Includes a complimentary EIN Presswire account plus 1-free release
  • Uncluttered & advertising free news pages

Company News Today by EIN Newsdesk & EIN Presswire (a press release distribution service)

Follow EIN Presswire on Facebook, LinkedIn and Substack

Newsmatics Inc., 1025 Connecticut Avenue NW, Suite 1000, Washington, DC 20036 · Contact · About

© 1995-2026 Newsmatics Inc. · All Rights Reserved · General Terms & Conditions · Privacy Policy · Cookie Settings

By continuing to use this site, you agree to our Terms & Conditions, last updated on September 30, 2025.